-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, LAQFanojRz3b6HEi+KYq866CT5Ww8DTg4D/dzWXyJhy0CELvcOjbxlCccizwSjHC 1OZi7LOXfjengkkPlYe/RQ== 0000950130-95-000747.txt : 19950427 0000950130-95-000747.hdr.sgml : 19950427 ACCESSION NUMBER: 0000950130-95-000747 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950410 ITEM INFORMATION: Other events FILED AS OF DATE: 19950420 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: 2834 IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10432 FILM NUMBER: 95529905 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 908-389-11 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 CURRENT REPORT FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 1995 Roberts Pharmaceutical Corporation - - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 1-10432 22-2429994 - - ----------------- ------------ -------------- (State or other (Commission (IRS Employer jurisdiction File Number) Identification of incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - - -------------------------------------------------------------------------------- (Address of principal executive office, including zip code) Registrant's telephone number, including area code: (908) 389-1182 - - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report.) Item 5. Other Events. ------------- On April 10, 1995, a shareholders' class action suit was instituted in the United States District Court for the District of New Jersey against Roberts Pharmaceutical Corporation ("Roberts" or the "Company") and certain of its officers by Grace Cowitt on behalf of all persons who purchased shares of the Company's common stock between November 7, 1994 and March 22, 1995. In her complaint, the plaintiff asserts claims against the Company and certain of its officers for violations of Section 10(b) and 20(a) of the Securities and Exchange Act of 1934, as amended, and Rule 10b-5 promulgated thereunder with respect to press releases and filings with the Securities and Exchange Commission and certain public statements allegedly made by the Company and certain of its officers relating to its business. The plaintiff seeks to recover damages in an unspecified amount. Roberts believes that it has complied with all of its obligations under the federal securities laws. Accordingly, the Company intends to vigorously defend against the plaintiff's allegations and considers such allegations to be without merit. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Roberts Pharmaceutical Corporation ---------------------------------- (Registrant) By: /s/ Anthony A. Rascio ------------------------------ Anthony A. Rascio Vice President Date: April 10, 1995 -----END PRIVACY-ENHANCED MESSAGE-----